The Impact of Endovascular Therapy for Aorto-iliac TASC D Lesions

The Impact of Endovascular Therapy for Aorto-iliac TASC D Lesions - The Impact of Endovascular Therapy for Aorto-iliac TASC D Lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013989

Enrollment

2000

Registered

2014-05-19

Start date

2012-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: From Jan. 2005 to Dec. 2009, consecutive patients undergoing stent deployment for de novo aortoiliac lesions were enrolled.

Exclusion criteria

Exclusion criteria: asymptomatic or unknown symptom before EVT, treatment with angioplasty alone, restenotic lesions, history of lower extremities bypass surgery or EVT, acute onset limb ischemia

Design outcomes

Primary

Measure	Time frame
In TASC D patients, independent predictors for MACLE.	—

Secondary

Measure	Time frame
Success rate, complicatoin rate, primary patency, and MACLE of TASC D and A-C,	—

Countries

Japan

Contacts

Public ContactKenji Suzuki

REAL-AI TASC D subanalysis

k-y.suzuki@nifty.com022-222-6181

Outcome results